Pacific Edge, which is banking on successfully commercialising its Cxbladder urine testing product, widened its first-half loss as it ramps up spending to set up its business in the US.
The Dunedin-based company made a loss of $3.2 million, or 1.2 cents per share, in the six months ended September 30, from $1.7 million, or 0.9 cents, a year earlier, it says in a statement.
Revenue climbed 29% to $325,000, though just $11,000 of that came from external customers.
"The majority of this net loss is the investment in the company's setting up of business in the US, clinical trials, product development and intellectual property as it is expensed," it says.
"The company is investing significant funds in the set-up and running of the commercial laboratory and the development of the US strategy in this financial year."
The shares fell 2.2% to 44 cents, having surged 137% this year. That values the company at $122.7 million.
Pacific Edge hopes to successfully bring its urine sampling system to market, having won clinical confirmation the Cxbladder is at least as effective as other methods from the American Journal of Urology.
The local company says that could be worth up to $100 million in five years.
Last month, the company completed its US lab in Pennsylvania and is waiting on regulatory approval to use the building.
This article is tagged with the following keywords. Find out more about MyNBR Tags
- Three fintech start-ups pitch for funds at end of Kiwibank-sponsored accelerator
- MARKET CLOSE: NZ stocks slip as Manchester concert attack drags on investor sentiment, Comvita drops
- NZ dollar climbs above 70 US cents on relatively upbeat kiwi fundamentals
- Xero makes a special alteration to rival's billboard
- Lindsay makes first investment since selling Sistema
Most listened to
- Business leaders on Budget 2017: Failure to set up any significant public-private partnerships for infrastructure is "really disappointing," says Paul Glass
- Serko’s Darrin Grafton says the company can use its SME platform to expand globally
- Trump travels overseas selling jobs as North Korea continues to lash out, on Trump’s Beltway with Nathan Smith
- Nick Shewring says co-working attracts "awesome people doing cool things"
- NBR Radio: best of the week ended May 19, with Grant Walker